# Laura Young, Chapel Hill, NC – FDA Inspections

Source: https://www.keypedia.com/companies/laura-young/8bda8821-7fe9-42e8-8a31-24a7576626ba

> Inspection records and compliance data for Laura Young in Chapel Hill, North Carolina. 1 FDA inspection on record, last inspected January 25, 2019.

---

## Details

- Name: Laura Young
- FEI Number: 3014835463
- Address Line 1: Unc Diabetes Care Center, 300 Meadowmont Village Cir Ste 201
- City: Chapel Hill
- State: North Carolina
- Zip Code: 27517
- Country Name: United States
- Address: Unc Diabetes Care Center, 300 Meadowmont Village Cir Ste 201, Chapel Hill, North Carolina 27517, United States
- Country: United States

## Related Documents

- FDA Inspection 1078947 - Laura Young - 2019-01-25 — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2019

## Related Companies

- [Premier Research and Consulting](https://www.keypedia.com/companies/premier-research-and-consulting/3c2e0ed5-2df4-4f2a-810a-5e074b74ad11)
- [Pfizer Inc](https://www.keypedia.com/companies/pfizer-inc/2eadc27f-4a60-4ead-a4ae-730856cf2f36)
- [Biocryst Pharmaceuticals, Inc.](https://www.keypedia.com/companies/biocryst-pharmaceuticals-inc/adfbc327-4431-4aa4-a13e-0c65fb2fb49f)
- [Cempra Inc](https://www.keypedia.com/companies/cempra-inc/2a0c8416-4f94-419e-9d78-94a3b6af7b6e)
- [Emad M. Hasan, M.D.](https://www.keypedia.com/companies/emad-m-hasan-md/b0bcdb2e-baab-4f83-9ca9-ef9d25f81e7a)
- [Richard Shultzaberger, M.D.](https://www.keypedia.com/companies/richard-shultzaberger-md/ffd3f202-1303-4684-a58b-8b945d7579b7)
- [Innospec Active Chemicals, LLC](https://www.keypedia.com/companies/innospec-active-chemicals-llc/d9989f09-9e99-459e-bcbd-1ee9d9743a18)
- [Mylan Pharmaceuticals Inc](https://www.keypedia.com/companies/mylan-pharmaceuticals-inc/031dfb60-545c-4edf-b0b8-c253945f271b)
- [Craig F. LaForce, MD](https://www.keypedia.com/companies/craig-f-laforce-md/457ca4b5-d6af-4466-8c2c-25a6ef7157cb)
- [Matthew Acampora, Clinical Investigator](https://www.keypedia.com/companies/matthew-acampora-clinical-investigator/05c458f4-732e-4bb7-ace8-74067591ff03)